Detalles de la búsqueda
1.
Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients.
Biol Blood Marrow Transplant
; 26(4): 745-757, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31756539
2.
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
Biol Blood Marrow Transplant
; 25(5): 955-964, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30605731
3.
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
Biol Blood Marrow Transplant
; 25(7): 1325-1330, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30716454
4.
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant
; 25(4): 699-711, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30423480
5.
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica
; 104(4): 844-854, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30381298
6.
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.
Biol Blood Marrow Transplant
; 24(1): 175-184, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28958894
7.
Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
Biol Blood Marrow Transplant
; 22(6): 1108-1116, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27013014
8.
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
Blood
; 123(23): 3655-63, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24735965
9.
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.
Biol Blood Marrow Transplant
; 26(6): e142-e144, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147534
10.
Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era.
Biol Blood Marrow Transplant
; 21(1): 142-50, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445638
11.
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.
Biol Blood Marrow Transplant
; 21(1): 165-71, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316111
12.
National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery.
Biol Blood Marrow Transplant
; 21(7): 1308-14, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25840337
13.
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Biol Blood Marrow Transplant
; 21(10): 1830-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26116089
14.
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Blood
; 121(1): 197-206, 2013 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23109243
15.
Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services.
Transfusion
; 54(6): 1501-7, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24383419
16.
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.
Blood
; 114(13): 2606-16, 2009 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-19608747
17.
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.
Blood
; 113(15): 3604-11, 2009 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19190248
18.
Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.
Transplant Cell Ther
; 27(2): 184.e1-184.e13, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045385
19.
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study.
Transplant Cell Ther
; 27(4): 352.e1-352.e5, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836890
20.
Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults.
Bone Marrow Transplant
; 55(5): 906-917, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740767